Detalles de la búsqueda
1.
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.
Pharmacoepidemiol Drug Saf
; 30(4): 445-450, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33295644
2.
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.
Eur J Cancer Care (Engl)
; 29(5): e13250, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406593
3.
Communication about Drug-Related Problems (DRPs) during Patients' Visits to Dutch Physicians and Pharmacies.
Health Commun
; 35(2): 201-208, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30526088
4.
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.
Eur Respir J
; 52(6)2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30487206
5.
Incentivizing appropriate prescribing in primary care: Development and first results of an electronic health record-based pay-for-performance scheme.
Health Policy
; 126(10): 1010-1017, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870964
6.
'Care for Outcomes': systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer.
BMJ Open
; 11(1): e043229, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33452199
7.
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.
Pharmacoecon Open
; 5(1): 121-127, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533521
8.
Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
JCO Clin Cancer Inform
; 5: 570-578, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010031
9.
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.
Sci Rep
; 11(1): 6306, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737641
10.
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.
Eur J Clin Pharmacol
; 66(11): 1143-50, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20658130
Resultados
1 -
10
de 10
1
Próxima >
>>